Trials / Completed
CompletedNCT00755352
A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Pravastatin for at Least 4 Weeks.
Efficacy of WelChol as an Add-on to Pravastatin Therapy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 67 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Determine the effect of WelChol tablets on serum lipids, lipoproteins, apolipoproteins, and lipoprotein particle size in patients who were stabilized on pravastatin therapy for at least 4 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pravastatin tablets and Welchol tablets | pravastatin tablets, 1 tablet/day for 6 weeks; Welchol Tablets, 6 tablets/day for 6 weeks |
| DRUG | pravastatin tablets and Welchol placebo tablets | pravastatin tablets, 1 tablet/day; Welchol placebo tablets, 6 tablets/day |
Timeline
- Start date
- 2002-11-01
- Primary completion
- 2003-06-01
- Completion
- 2005-04-01
- First posted
- 2008-09-18
- Last updated
- 2015-04-03
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00755352. Inclusion in this directory is not an endorsement.